Emergent BioSolutions (EBS) Gains from Investment Securities (2010 - 2026)
Emergent BioSolutions (EBS) recorded quarterly Gains from Investment Securities of $3.9 million in Q1 2026, up 875.0% quarter-over-quarter from $400000.0 in Q4 2025, and down 65.49% on a YoY basis from $11.3 million in Q1 2025.
Emergent BioSolutions (EBS) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 65.49% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $4.3 million (down 63.87% YoY), while the FY2025 annual figure was $1.4 million, up 27.27% from the prior year.
- Gains from Investment Securities was $3.9 million for Q1 2026 at Emergent BioSolutions, up from $400000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $11.3 million in Q1 2025 to a low of -$1.1 million in Q3 2023.
- Historically, Gains from Investment Securities has averaged $1.8 million across 5 years, with a median of $450000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities tumbled 283.33% in 2023, then jumped 1133.33% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $200000.0 in 2022, then tumbled by 50.0% to $100000.0 in 2023, then jumped by 400.0% to $500000.0 in 2024, then dropped by 20.0% to $400000.0 in 2025, then soared by 875.0% to $3.9 million in 2026.
- The last three Gains from Investment Securities figures came in at $3.9 million (Q1 2026), $400000.0 (Q4 2025), and $11.3 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 11.30 Mn |
| Mar 31, 2025 | 11.30 Mn |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 3.10 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | -1.10 Mn |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | -300,000.00 |
| Mar 31, 2023 | -300,000.00 |